Lysostaphin: model for a specific enzymatic approach to infectious disease.
about
Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfacesLysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat modelLysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin.Recombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumoniaBiological properties of the encapsulated Staphylococcus aureus M.Biochemical characterization and evaluation of cytotoxicity of antistaphylococcal chimeric protein P128.Lysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo.Gene and protein sequence optimization for high-level production of fully active and aglycosylated lysostaphin in Pichia pastoris.Pseudomonas aeruginosa LasA protease in treatment of experimental staphylococcal keratitis.Peptidoglycan hydrolases-potential weapons against Staphylococcus aureusMechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis.Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol.epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureusHigh-level potentiation of lysostaphin anti-staphylococcal activity by lysozymeAntigenic response to topically applied proteins.Rapid identification of Staphylococcus aureus by using lysostaphin sensitivity.Effect of various blood culture media on lysostaphin sensitivity of staphylococci.Mutation analysis of the histidine residues in the glycylglycine endopeptidase ALE-1.Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization
P2860
Q24650674-7D03ED17-EEAF-412D-975B-D57EED571FA6Q24682172-3D2BC726-52F8-49CB-A7CB-8DE944E8A025Q28379547-9D6E6134-E2CC-4B85-9664-70657E993AEDQ33664443-0FE0B0D9-FBE8-448F-9233-AF73F0E57E24Q33938244-E440D341-BE60-46DD-B10D-72EFFEB6F679Q33977229-9E29D9B9-D4E6-44CF-9308-7BC7BBE91C4FQ34012319-C7D195EC-2CC9-474C-9444-2BD94C6C8DBDQ34112836-BF0080AB-BDA6-406C-9F82-625B4E51101AQ34298267-3B2AAFA3-29D5-44EE-9A17-6E19AB2AB49BQ35635997-1D8CFE29-D32D-4270-98C9-9B4759165522Q37713110-D612D0D8-A422-47C3-8F22-C96A700A9495Q37733684-94EEA523-5EF9-4732-AB62-9273068D61E4Q38053102-7A63878C-E571-4941-9D49-9C64D83BE866Q39477127-E06653AA-809D-4BDD-9FB8-F6A6F5B209A4Q39651918-7A84D82C-D800-4781-A193-28481EE1C4EBQ39740458-A6720E49-25B3-4239-B934-2B4B2DC11FE0Q39846360-6E56D7F9-B71C-4212-BEE2-74BE1EC79CCEQ39856762-9166F146-FEE7-4F39-865E-C77BAE670F71Q39918312-13A0B1FE-B923-43EA-9E55-800BCB050BC0Q40230502-BCE9462C-22C7-4884-8373-FFE60D5FD645Q40231375-E1566FC4-B286-4117-B4C9-02D0DE8C7B3BQ40875374-6255ACEF-B00F-400D-8F59-D3BB3E514A64Q40968033-3F42717B-9256-467A-AE6B-DFF4D0D4B253
P2860
Lysostaphin: model for a specific enzymatic approach to infectious disease.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh
1972年學術文章
@zh-hant
name
Lysostaphin: model for a specific enzymatic approach to infectious disease.
@en
Lysostaphin: model for a specific enzymatic approach to infectious disease.
@nl
type
label
Lysostaphin: model for a specific enzymatic approach to infectious disease.
@en
Lysostaphin: model for a specific enzymatic approach to infectious disease.
@nl
prefLabel
Lysostaphin: model for a specific enzymatic approach to infectious disease.
@en
Lysostaphin: model for a specific enzymatic approach to infectious disease.
@nl
P1476
Lysostaphin: model for a specific enzymatic approach to infectious disease
@en
P2093
Tavormina PA
Zygmunt WA
P304
P577
1972-01-01T00:00:00Z